A systematic review of the adverse events and economic impact associated with oral corticosteroids in asthma.
CONCLUSIONS: The use of OCS in the management of asthma is associated with a higher risk of complications. This risk is higher as the OCS dose increases.
PMID: 30513226 [PubMed - as supplied by publisher]
Source: Journal of Asthma - Category: Respiratory Medicine Tags: J Asthma Source Type: research
More News: Asthma | Corticosteroid Therapy | Databases & Libraries | Diabetes | Diabetes Mellitus | Endocrinology | Hypertension | Respiratory Medicine | Study